{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:22:07Z","timestamp":1789384927014,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,2]]},"DOI":"10.1097\/qad.0b013e32833f9e04","type":"journal-article","created":{"date-parts":[[2010,10,8]],"date-time":"2010-10-08T07:41:08Z","timestamp":1286523668000},"page":"49-55","source":"Crossref","is-referenced-by-count":30,"title":["Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART"],"prefix":"10.1097","volume":"25","author":[{"given":"Brian C","family":"Zanoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuli","family":"Phungula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly M","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"France","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(07)61051-4","article-title":"International perspectives, progress, and future challenges of paediatric HIV infection","volume":"370","author":"Prendergast","year":"2007","journal-title":"Lancet"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1542\/peds.106.6.e77","article-title":"Morbidity among human immunodeficiency virus-1-infected and -uninfected African children","volume":"106","author":"Taha","year":"2000","journal-title":"Pediatrics"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1542\/peds.2007-0273","article-title":"Increasing antiretroviral drug access for children with HIV infection","volume":"119","author":"Havens","year":"2007","journal-title":"Pediatrics"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.298.16.1888","article-title":"Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary healthcare facilities in Zambia","volume":"298","author":"Bolton-Moore","year":"2007","journal-title":"JAMA"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/INF.0b013e3181bf8ecb","article-title":"Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in lesotho","volume":"29","author":"Leyenaar","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R7-6-20210130","first-page":"225","article-title":"Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting","volume":"12","author":"Cotton","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/595012","article-title":"High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies","volume":"48","author":"Hesseling","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R10-6-20210130","first-page":"862","article-title":"HAART and risk of tuberculosis in HIV-infected South African children: a multisite retrospective cohort","volume":"13","author":"Martinson","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-10-23","article-title":"The tuberculosis challenge in a rural South African HIV programme","volume":"10","author":"Houlihan","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2431-7-13","article-title":"Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa","volume":"7","author":"Reddi","year":"2007","journal-title":"BMC Pediatr"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2249.2001.01401.x","article-title":"Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients","volume":"123","author":"Toossi","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 3","key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1086\/521116","article-title":"Challenges to pediatric HIV care and treatment in South Africa","volume":"196","author":"Meyers","year":"2007","journal-title":"J Infect Dis"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00042560-200112150-00007","article-title":"Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis","volume":"28","author":"Ribera","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.aids.0000183519.45137.a6","article-title":"Pharmacokinetic interactions between efavirenz and rifampicin in the treatment of HIV and tuberculosis: one size does not fit all","volume":"19","author":"Brennan-Benson","year":"2005","journal-title":"AIDS"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/dkm484","article-title":"Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis","volume":"61","author":"Cohen","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R19-6-20210130","first-page":"85","article-title":"Updated guidelines for the use of rifamycins in HIV\/TB-coinfected patients.","volume":"16","author":"del Rio","year":"2004","journal-title":"AIDS Clin Care"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.48.5.1553-1560.2004","article-title":"Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers","volume":"48","author":"la Porte","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-6-20210130","first-page":"675","article-title":"HIV and childhood tuberculosis: the way forward","volume":"8","author":"Cotton","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R28-6-20210130","first-page":"844","article-title":"Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data","volume":"2","author":"Coovadia","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"R29-6-20210130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAI.0b013e31805c9d52","article-title":"High prevalence of subtherapeutic plasma concentrations of efavirenz in children","volume":"45","author":"Ren","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-6-20210130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0b013e3181642257","article-title":"Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis","volume":"47","author":"Ren","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-6-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11904-007-0010-0","article-title":"Adherence-resistance relationships to combination HIV antiretroviral therapy","volume":"4","author":"Bangsberg","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R33-6-20210130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.aids.0000199825.34241.49","article-title":"Adherence-resistance relationships for protease and nonnucleoside reverse transcriptase inhibitors explained by virological fitness","volume":"20","author":"Bangsberg","year":"2006","journal-title":"AIDS"},{"key":"R34-6-20210130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.157.3.1271","article-title":"Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation","volume":"157","author":"Goletti","year":"1996","journal-title":"J Immunol"},{"key":"R35-6-20210130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jmv.20257","article-title":"Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with antituberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire","volume":"75","author":"Kalou","year":"2005","journal-title":"J Med Virol"},{"key":"R36-6-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1468-1293.2007.00442.x","article-title":"Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients","volume":"8","author":"Mallolas","year":"2007","journal-title":"HIV Med"},{"key":"R37-6-20210130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31802b920e","article-title":"Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine","volume":"44","author":"Martinson","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R38-6-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/590160","article-title":"Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission","volume":"198","author":"Flys","year":"2008","journal-title":"J Infect Dis"},{"key":"R39-6-20210130","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/591503","article-title":"Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission","volume":"198","author":"Church","year":"2008","journal-title":"J Infect Dis"},{"key":"R40-6-20210130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa062876","article-title":"Response to antiretroviral therapy after a single, peripartum dose of nevirapine","volume":"356","author":"Lockman","year":"2007","journal-title":"N Engl J Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201101020-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:14Z","timestamp":1786041554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201101020-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833f9e04","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,2]]}}}